http://orcid.org/0000-0003-4723-2151
References
- Macaulay WL. Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign—histologically malignant. Archives Dermatol. 1968;97(1):23–30.
- Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 1993;28(6):973–980.
- Bekkenk MW, Geelen FAMJ, Vader PC van V, et al. Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95(12):3653.
- Liu HL, Hoppe RT, Kohler S, et al. Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49(6):1049–1058.
- Dawn G, Morrison A, Morton R, et al. Concise report co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Clin Exper Dermatol. 2003;28(6):620–624.
- Kunishige JH, McDonald H, Alvarez G, et al. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exper Dermatol. 2009;34(5):576–581.
- Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 1996;34(3):470–481.
- Kaudewitz P, Herbst H, Anagnostopoulos I, et al. Lymphomatoid papulosis followed by large‐cell lymphoma: immunophenotypical and genotypical analysis. Br J Dermatol. 1991;124(5):465–469.
- Mori M, Manuelli C, Pimpinelli N, et al. CD30-CD30 ligand interaction in primary cutaneous CD30+T-cell lymphomas: a clue to the pathophysiology of clinical regression. Blood. 1999;94(9):3077.
- Hoppe RT, Harrison C, Tavallaee M, et al. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol. 2015;72(2):286–292.
- Chowdhary M, Song A, Zaorsky NG, et al. Total skin electron beam therapy in mycosis fungoides—a shift towards lower dose? Chin Clin Oncol. 2019;8(1):2018.